FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/03/050322 [Registered on: 03/03/2023] Trial Registered Prospectively
Last Modified On: 01/03/2023
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Unani 
Study Design  Single Arm Study 
Public Title of Study   A clinical trial to compare the effects of an Unani Toothpaste with Herbo-mineral Toothpaste in patients with infection of gums that support the teeth 
Scientific Title of Study   A Single-Blind, Randomized, Parallel-Group Study to Compare Safety and Efficacy of an Unani Toothpaste with Herbo-mineral Toothpaste in Patients with Amrād Al-Asnān-o-Litha (Periodontal Diseases) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
AAL/PD/UT/RCT/CCRUM/21-22, version 01, 06/02/2023  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Prof Asim Ali Khan 
Designation  Director General  
Affiliation  Central Council for Research in Unani Medicine (CCRUM)  
Address  Room No. 502, Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

South West
DELHI
110058
India 
Phone  01128525715  
Fax    
Email  unanimedicine@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Naheed Parveen  
Designation  Assistant Director 
Affiliation  Central Council for Research in Unani Medicine (CCRUM)  
Address  Room No. 507, Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

South West
DELHI
110058
India 
Phone  9213511298   
Fax    
Email  ccrum507@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Pradeep Kumar 
Designation  Research Officer (Pathology) S-IV  
Affiliation  Central Council for Research in Unani Medicine (CCRUM)  
Address  Room No.516, Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

South West
DELHI
110058
India 
Phone  8800263300  
Fax    
Email  drpradeepkumar2001@yahoo.com  
 
Source of Monetary or Material Support  
Infrastructural support : 1 National Research Institute of Unani Medicine for Skin Disorders (NRIUMSD), Hyderabad Monetary Support : Central Council for Research in Unani Medicine (CCRUM), New Delhi  
 
Primary Sponsor  
Name  Central Council for Research in Unani Medicine CCRUM New Delhi  
Address  Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi-110058 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Arzeena Jabeen  National Research Institute of Unani Medicine for Skin Disorders (NRIUMSD), Hyderabad  Research OPD Amrād Al-Asnān-o-Litha (Periodontal Diseases), AG Colony Rd, Sunder Nagar
Hyderabad
TELANGANA 
9032519286

aarzu763@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
National Research Institute of Unani Medicine for Skin Disorders (NRIUMSD), Hyderabad  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K089||Disorder of teeth and supporting structures, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Dant-Rakshak (Herbo-mineral Toothpaste)   Use sufficient quantity (Paste) of toothpaste for brushing of teeth with Toothbrush  
Intervention  Sunoon-E-Musatahkam-E-Dandan (Unani Toothpaste)   Use sufficient quantity (Paste) of toothpaste for brushing of teeth with Toothbrush  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Healthy male and non-pregnant female
2. Aged between 18 and 65 years.
3. Willing to give signed written informed consent
4. Subjects having Amrād al-Asnān (disease of the teeth) with or without any of the following symptoms:
Bakhr al-Fam (halitosis)
Quruh al-Litha (gingival ulcer)
Taharruk al-Asnan (odontoseisis)
Waram al-Lissa (gingival swelling)
Humra al-Lissa (gingival erythema)
Nazf al-Lisa (gingival bleeding)
Dhahab Ma’ al-Asnan (sensitive teeth)
Waja‘ al-Asnān (toothache) 
 
ExclusionCriteria 
Details  1. Requirement for prophylactic antibiotic medication,
2. Unable to comply with a study schedule,
3. Untreated caries
4. Periodontitis requiring prompt treatment or
5. Emergency dental treatment,
6. Wearing any kind of oral appliance,
7. History of known allergies
8. Known case of Hemophilia, Low platelet count (thrombocytopenia) and von Willebrand disease (VWD), etc.
9. Known cases of any other acute illness.
10. Known cases of systemic disorders requiring prolonged treatment.
11. Pregnant and lactating women.
12. History of Hypersensitivity to the study drug or any of its ingredients. 
 
Method of Generating Random Sequence   Stratified block randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Improvement in sign and symptoms of Amrād Al-Asnān-o-Litha (Periodontal Diseases) on the basis of VAS scoring. The bleeding will be scored as per Modified Sulcus Bleeding Index Scoring Criteria.   At baseline, 14th day and 28th days. 
 
Secondary Outcome  
Outcome  TimePoints 
Haematological and biochemical assessment for safety assessment   At baseline and end of the treatment i.e. after 28days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   09/03/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is designed as a single blind randomized parallel group trial in patients with Amrād Al-Asnān-o-Litha (Periodontal Diseases).  Patients will be enrolled if they satisfy inclusion and exclusion criteria. The patients enrolled in the study will receive the medicine Sunoon-E-Musatahkam-E-Dandan (Unani Toothpaste)  or Dant-Rakshak (Herbo-mineral Toothpaste)  as allocated by randomization method. The total duration of treatment will be 28 days and the follow-up for all clinical parameters will be conducted on baseline, 14th and 28th day.

Rationale of study:

The Unani formulation Sunoon-e-Musatahkam-e-Dandan SMD (Unani Toothpowder) was developed into toothpaste by NIPER Hyderabad and preclinical safety study of the Unani Toothpaste (Sunoon-e-Musatahkam-e-Dandan) was also carried out by NIPER Hyderabad.   This study has been designed to assess the safety and efficacy of the Unani Toothpaste (SMD) in healthy volunteers. The SMD has been described in NFUM and its actions as mentioned are Dafi‘-i-Ta‘affun (antiseptic), Habis-i-Dam (hemostyptic). It is recommended to use in the conditions like Bakhr al-Fam (halitosis), Quruh al-Litha (gingival ulcer), Taharruk al-Asnan (odontoseisis). The SMD is an Unani formulation containing herbs and minerals which possess the Dafi‘-i-Ta‘affun (antiseptic), Muhallil Waram (resolvent of inflammation), Mujaffif (desiccant), Muqawwi-i-A‘sab (nervine tonic), Muqawwiyat-i-Asnan-o-Litha (tonics for gums and teeth), Musakkin-i-Alam (analgesic) activities [Anonumous, 2006].

The Sunoon-e-Musatahkam-e-Dandan has been in use for the treatment of Bakhr al-Fam (halitosis), Quruh al-Litha (gingival ulcer), and Taharruk al-Asnan (odontoseisis) since long by eminent Unani physicians. Therefore, this study is undertaken to validate the safety and efficacy of Unani Toothpowder which is a modified dosage form of SMD to promote its use in the general public.

Composition of Unani Toothpaste:

S. No

Unani Name (scientific name)

Role

Quantity

          1           

Mastagi (Pistacia lenticus L.)

Gum/resin

4 parts

          2           

Namak-e-Sambhar (Sambhar Lake salt)

Salt

4 parts

          3           

Kath Safaid (Acacia leucophloea Willd.)

White catechu

4 parts

          4           

Filfil Siyah (Piper nigrum L.)

Seed

4 parts

          5           

Azaraqi Sokhta (Strychnos nuxvomica L.)

Seed

4 parts

          6           

Shibb-e-Yamani Biryan (Alum)

Roasted alum

4 parts

          7           

Tutiya (Copper sulphate)

Blue vitriol

1 part

          8           

Sodium Chloride

Salt

TBD

          9           

Dicalcium phosphate

Abrasive

TBD

        10         

Calcium carbonate

Abrasive

TBD

        11         

Glycerin

Humectant

TBD

        12         

Gum tragacanth

Thickening agent

TBD

        13         

Saccharine

Sweetener

TBD

        14         

Sodium lauryl sulphate

Surfactant

TBD

        15         

Methylparaben

Preservative

TBD

        16         

Propylparaben

Preservative

TBD

        17         

Flavoring agent

Flavoring agent

TBD

        18         

Distilled water

Solvent

TBD

 
Close